A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Calcipotriene, Betamethasone Dipropionate (Calcipotriene and Betamethasone Dipropionate)

Vitamin D Analog class · 0 generic manufacturers · 0 ANDAs filed at FDA.

First FDA approval2020-01-30
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
$1.72/unit
2 NDCs benchmarked, lowest of all strengths.
Average NADAC
$2.28
Across all dosage forms in distribution.
Highest NADAC
$2.84
Range is tight.
Plans with PA
3 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema9 entries indexed · 4 visible
What is Calcipotriene, Betamethasone Dipropionate used for?

Calcipotriene, Betamethasone Dipropionate is a Vitamin D Analog medication tracked in Medicare Part D.

Is there a generic for Calcipotriene, Betamethasone Dipropionate?

No. Calcipotriene, Betamethasone Dipropionate is brand-only with no generic equivalents currently in market.

How much does my plan pay for Calcipotriene, Betamethasone Dipropionate?

Across 329 Part D plans, Calcipotriene, Betamethasone Dipropionate averages $2.28/unit (NADAC). Lowest available: $1.72/unit. Highest in distribution: $2.84/unit.

Is Calcipotriene, Betamethasone Dipropionate on the FDA shortage list?

No. Calcipotriene, Betamethasone Dipropionate is not currently on the FDA Drug Shortage Database.

5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Vitamin D Analog2 alternatives in D1
01
Calcipotriene
Brand: Calcitrene
$1.10Lowest NADAC
5Generic mfrs
$35.6MCY24 Part D spend
Compare →
02
Calcipotriene and Betamethasone Dipropionate
Brand: ENSTILAR
$0.886Lowest NADAC
3Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (2 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.